NEUROCYTONIX Trademark

Trademark Overview


On Wednesday, September 8, 2021, a trademark application was filed for NEUROCYTONIX with the United States Patent and Trademark Office. The USPTO has given the NEUROCYTONIX trademark a serial number of 97016422. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, February 28, 2025. This trademark is owned by NeuroCytonix, Inc.. The NEUROCYTONIX trademark is filed in the Medical Instrument Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical treatment of non-progressive and progressive brain diseases, conditions of the central and peripheral nervous system, neurological and psychiatric disorders, and spinal cord injuries, using magnetic resonance modulation, radio frequency cell signaling technology, and rotational field quantum magnetic resonance

Neural tissue engineering apparatus for medical use of instantaneous magnetic fields and low spectrum radio frequency waves for neurological therapeutic purposes; Magnetic resonance imaging (MRI) apparatus for medical purposes to target nervous system lesions and modulate a signal to stimulate cell growth and cell repair in human nervous system for treatment of non-progressive and progressive brain diseases, conditions of the central and peripheral nervous system, neurological and psychiatric disorders, and spinal cord injuries
neurocytonix

General Information


Serial Number97016422
Word MarkNEUROCYTONIX
Filing DateWednesday, September 8, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, February 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements


Goods and ServicesMedical treatment of non-progressive and progressive brain diseases, conditions of the central and peripheral nervous system, neurological and psychiatric disorders, and spinal cord injuries, using magnetic resonance modulation, radio frequency cell signaling technology, and rotational field quantum magnetic resonance
Goods and ServicesNeural tissue engineering apparatus for medical use of instantaneous magnetic fields and low spectrum radio frequency waves for neurological therapeutic purposes; Magnetic resonance imaging (MRI) apparatus for medical purposes to target nervous system lesions and modulate a signal to stimulate cell growth and cell repair in human nervous system for treatment of non-progressive and progressive brain diseases, conditions of the central and peripheral nervous system, neurological and psychiatric disorders, and spinal cord injuries

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, January 24, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 24, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeuroCytonix, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameNeuroCytonix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Saturday, September 11, 2021NEW APPLICATION ENTERED
Monday, October 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 21, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, October 21, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, June 13, 2022ASSIGNED TO EXAMINER
Monday, June 13, 2022NON-FINAL ACTION WRITTEN
Monday, June 13, 2022NON-FINAL ACTION E-MAILED
Monday, June 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 24, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 24, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, January 24, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 24, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, January 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 8, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 8, 2023SOU EXTENSION 1 FILED
Thursday, June 8, 2023SOU EXTENSION 1 GRANTED
Saturday, June 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 27, 2024SOU EXTENSION 2 GRANTED
Tuesday, February 27, 2024SOU EXTENSION 2 FILED
Wednesday, February 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 27, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 26, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 26, 2024SOU EXTENSION 3 FILED
Thursday, September 26, 2024SOU EXTENSION 3 GRANTED
Friday, February 28, 2025SOU TEAS EXTENSION RECEIVED
Friday, February 28, 2025SOU EXTENSION 4 FILED
Saturday, March 1, 2025SOU EXTENSION 4 GRANTED
Sunday, March 2, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED